Tocilizumab: An Effective Therapy for Severely and Critically Ill COVID-19 Patients
Ajeet Singh, Sudhir Bhandari, Govind Rankawat
Abstract
Bhandari S, Rankawat G, Singh A. Tocilizumab: An Effective Therapy for Severely and Critically Ill COVID-19 Patients. Indian J Crit Care Med 2021;25(3):260-266.
Topics & Concepts
MedicineTocilizumabMechanical ventilationInternal medicineCoronavirus disease 2019 (COVID-19)Critically illInfusion therapyRetrospective cohort studyAnesthesiaInfectious disease (medical specialty)DiseaseCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 Research